AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dymozen-AQ Injection

Prescription Icon
Prescription Required

Marketer

Dymocare Pharmaceutical Pvt. Ltd.

Salt Composition

Diclofenac (75mg)

Overview Dymozen-AQ Injection

Aquazene injection provides analgesia, alleviating pain, inflammation, and stiffness associated with joint conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral routes are infeasible. This injectable medication should only be administered by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (heart disease or stroke) must inform their physician. Report any injection site reactions (pain, swelling, erythema) to your doctor immediately. Common adverse effects include nausea, emesis, cephalalgia, and local injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematologic parameters. Extended use carries a risk of severe complications, including gastrointestinal hemorrhage and nephropathy.

Primary Ingredients of Dymozen-AQ Injection

The provided text is "undefined". Therefore, no rephrasing is possible.

Uses of Dymozen-AQ Injection

Analgesia

Major Benefits of Dymozen-AQ Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Dymozen-AQ Injection:

  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Flatulence
  • Edema (swelling)
  • Nausea
  • Headache
  • Dizziness

How to use Dymozen-AQ Injection:

Administering this medication will be done by your physician or their associate; self-medication is strongly discouraged.

How Dymozen-AQ Injection works:

Aquazene injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and associated swelling and redness.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Dymozen-AQ Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Dymozen-AQ Injection to pregnant individuals is contraindicated due to confirmed risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Dymozen-AQ Injection while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Administering Dymozen-AQ Injection might impair driving capabilities due to potential adverse reactions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, administration of Dymozen-AQ Injection requires careful consideration. The prescribed dosage of Dymozen-AQ Injection might necessitate modification. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Dymozen-AQ Injection judiciously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Dymozen-AQ Injection :

Omit a Dymozen-AQ Injection dose? Seek your physician's advice.

Facts to Know About Dymozen-AQ Injection

LabelValue
Chemical Category Phenylacetic acid derivative
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Dymozen-AQ Injection

Dymozen-AQ Injection must be administered only by a healthcare professional. Intramuscular (preferably in the buttock), subcutaneous, or intravenous bolus injection is acceptable; infusion is not. The prescribed dose must not be exceeded, and treatment should not last longer than two days.
Dymozen-AQ Injection may increase your risk of heart attack or stroke, particularly with higher doses or prolonged use. It can also cause stomach and intestinal ulcers, bleeding, or perforation, potentially life-threatening and without warning. Seek immediate medical attention if you experience any such symptoms.
Dymozen-AQ Injection provides effective pain and inflammation relief. Its uses include sprains, strains, other injuries, various arthritic conditions, gout, and post-surgical pain and inflammation.
Prolonged or high-dose Dymozen-AQ Injection may lead to renal complications, including proteinuria, hematuria, and dysuria. Individuals with pre-existing kidney impairment, heart failure, hypertension, dehydration, or those taking diuretics or nephrotoxic medications, particularly the elderly, are at increased risk. Therefore, kidney function monitoring is advised for these patients.
Dymozen-AQ Injection may cause drowsiness, dizziness, fatigue, and visual disturbances, although these side effects are uncommon. Avoid driving or operating machinery if you experience any of these symptoms.
Avoid Dymozen-AQ Injection during pregnancy, especially the last trimester, due to potential harm to the baby and the risk of premature delivery. Its use should also be avoided during the first six months. Prescription during pregnancy should only occur when the potential benefits clearly surpass the risks. Always consult your doctor before using Dymozen-AQ Injection if you are pregnant.
Dymozen-AQ Injection is not a recreational drug; it has no potential for abuse or dependence. If you experience any adverse effects, contact your physician.
Dymozen-AQ Injection is not a narcotic; it's a non-steroidal anti-inflammatory drug (NSAID).
Dymozen-AQ Injection
24
MRP 28
14% off